Regeneron Covid-19 Drug

AstraZeneca therapy works against omicron; results mixed for Regeneron
Coronavirus chronicle

AstraZeneca therapy works against omicron; results mixed for Regeneron

AstraZeneca said a lab study found that its antibody cocktail Evusheld retained neutralising activity against omicron, the first such data for the treatment

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020. REUTERS/Brendan McDermid
Coronavirus chronicle

Regeneron says Covid-19 drug could be less effective against Omicron variant

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020. REUTERS/Brendan McDermid
Coronavirus chronicle

Regeneron's Covid antibody drug shows protection for up to 8 months

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, US September 17, 2020/ Reuters
Coronavirus chronicle

Germany wants to use Regeneron's Covid-19 antibody therapy more broadly